Heartflow, Inc. $HTFL Shares Bought by Summit Partners Public Asset Management LLC

Summit Partners Public Asset Management LLC grew its holdings in shares of Heartflow, Inc. (NASDAQ:HTFL) by 48.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,259,121 shares of the company’s stock after acquiring an additional 410,659 shares during the period. Summit Partners Public Asset Management LLC owned about 1.48% of Heartflow worth $36,703,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Wellington Management Group LLP acquired a new stake in shares of Heartflow during the third quarter valued at about $164,263,000. Schusterman Interests LLC acquired a new stake in shares of Heartflow during the third quarter valued at about $65,274,000. Vanguard Group Inc. grew its stake in shares of Heartflow by 8.8% during the fourth quarter. Vanguard Group Inc. now owns 1,580,313 shares of the company’s stock valued at $46,066,000 after acquiring an additional 128,400 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Heartflow during the fourth quarter valued at about $41,714,000. Finally, Capital International Investors acquired a new stake in shares of Heartflow during the third quarter valued at about $43,671,000.

Heartflow Stock Performance

Shares of HTFL stock opened at $32.05 on Wednesday. Heartflow, Inc. has a one year low of $20.13 and a one year high of $41.22. The company’s 50-day simple moving average is $29.60 and its 200-day simple moving average is $28.33. The stock has a market capitalization of $2.76 billion and a price-to-earnings ratio of -10.31.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The company’s revenue was up 41.3% on a year-over-year basis. As a group, research analysts forecast that Heartflow, Inc. will post -0.82 EPS for the current year.

Insiders Place Their Bets

In other Heartflow news, CEO John C.M. Farquhar sold 22,562 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $29.12, for a total value of $657,005.44. Following the transaction, the chief executive officer owned 519,397 shares of the company’s stock, valued at $15,124,840.64. This trade represents a 4.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 64,533 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $24.64, for a total transaction of $1,590,093.12. Following the completion of the transaction, the insider directly owned 81,002 shares in the company, valued at $1,995,889.28. This represents a 44.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,205,971 shares of company stock valued at $64,308,951 over the last quarter. Insiders own 7.70% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Canaccord Genuity Group reduced their price target on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. Wells Fargo & Company increased their price target on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. JPMorgan Chase & Co. reduced their price target on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, March 19th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday. Finally, William Blair assumed coverage on shares of Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $37.00.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.